NCT06014853 - A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

October 28, 2023

Study Completion Date

November 16, 2023

Conditions

Prostate Cancer

Interventions

DRUG

SOL-804-F

All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with water on the administration day of each period.

DRUG

Zytiga

All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with water on the administration day of each period.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul